v3.26.1
Discontinued Operations - Cash Flows from Discontinued Operations (Details) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net cash provided by operating activities from discontinued operations $ 4,053,236 $ 5,442,288
Cash flows from investing activities:    
Increase of investment in manufacturing (145,459) (857,680)
Cash flows from financing activities:    
Cash settlement of contingent consideration (848,731) (654,757)
Discontinued Operations, Held-for-Sale | FDA-Approved Brands    
Cash flows from operating activities:    
Intangible assets, net 2,488,795 1,987,733
Inventories, net 866,780 777,123
Prepaid and other current assets 678,903 899,907
Other assets 681,989 1,039,190
Other current liabilities (855,669) 686,201
Other long-term liabilities 192,438 52,134
Net cash provided by operating activities from discontinued operations 4,053,236 5,442,288
Cash flows from investing activities:    
Increase of investment in manufacturing (145,459) (857,680)
Cash flows from financing activities:    
Cash settlement of contingent consideration $ (848,731) $ (654,757)